The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 29, 2022

Filed:

Aug. 05, 2016
Applicant:

Toray Industries, Inc., Tokyo, JP;

Inventors:

Akira Kurihara, Kamakura, JP;

Fumiyoshi Okano, Kamakura, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/47 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61K 39/39 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); A61K 35/15 (2015.01); A61K 35/76 (2015.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 35/15 (2013.01); A61K 35/17 (2013.01); A61K 35/76 (2013.01); A61K 39/00 (2013.01); A61K 39/39 (2013.01); A61K 45/00 (2013.01); A61K 48/00 (2013.01); A61P 35/00 (2018.01); C07K 14/47 (2013.01); C07K 14/4702 (2013.01); C12N 5/10 (2013.01); C12N 15/09 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/53 (2013.01); A61K 2039/572 (2013.01);
Abstract

An object of the present invention is to discover a novel peptide useful as an active ingredient in an agent for treating or preventing cancer, and to provide the use of the polypeptide as an immune inducer. The immune inducer contains as an active ingredient, the following (i) or (ii): (i) at least one polypeptide having an immune-inducing activity and selected from the group of polypeptides (a) or (b), where: (a) polypeptides consisting of 7 or more consecutive amino acids within the region of positions 24 to 97 in the amino acid sequence represented by SEQ ID NO: 2; and (b) polypeptides comprising one to several amino acid deletions, substitutions and/or additions in the amino acid sequence of any one of the polypeptides (a); and (ii) a recombinant vector comprising at least one polynucleotide encoding any one of the polypeptides, and capable of expressing the polypeptide in vivo.


Find Patent Forward Citations

Loading…